Matsuzaka et al demonstrated in Elovl6 −/− mice that the loss of Elovl6 function protected from high-fat induced hyperinsulinemia, hyperglycemia and hyperleptinemia, the fundamental signs of obesity and diabetes, despite the development of obesity and hepatosteatosis [10]. Here, ELOVL6 is linked to obesity due to melanocortin 4 receptor deficiency.